Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.3%

1 terminated/withdrawn out of 16 trials

Success Rate

92.9%

+6.4% vs industry average

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

0%

0 of 13 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(85.7%)
Phase 3
1(14.3%)
7Total
N/A(6)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT06707818Completed

Psychosocial Factors and Postoperative Pain in Aesthetic Breast Surgery

Role: lead

NCT05284695Completed

The EFFICIENCY of FASCIAL PLANE BLOCKS in BARIATRIC SURGERY

Role: lead

NCT06705595Not ApplicableCompleted

The Effect of Local Anesthetic Techniques on Hemodynamic Response and Postoperative Sore Throat in Double-Lumen Tubes

Role: lead

NCT06138119Not ApplicableCompleted

The Impact of Gender Stereotypes on Fiberoptic Intubation Performance

Role: lead

NCT04770129Completed

Real-World Data on Clinical Characteristics, Demographics, and Outcomes of Patients With Metastatic Breast Cancer in Turkey

Role: collaborator

NCT05242198Not ApplicableCompleted

Rectus Sheath Block May Relieve Urethral Catheter Pain

Role: lead

NCT05241977Completed

MINIMUM EFFECTIVE VOLUME OF BUPIVACAİNE FOR ANTERIOR SUPRASCAPULAR NERVE BLOCK

Role: lead

NCT05282303Completed

REGIONAL ANALGESIA TECHNIQUES FOR EFFECTIVE RECOVERY TO CORONARY ARTERY BYPASS SURGERIES: A RETROSPECTİVE STUDY IN A SINGLE CENTER EXPERIENCE

Role: lead

NCT03774862Completed

Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study

Role: lead

NCT03744377Unknown

Validation ( Endometriosis Health Profile) EHP-30 (Turkish Version) for Patients With Endometriosis

Role: lead

NCT01162447Unknown

Comparison of Bone Morphogenetic Protein-4 (BMP-4) and 7 Levels Between Control and Polycystic Ovarian Syndrome (PCOS) Patients.

Role: lead

NCT01007851Phase 3Terminated

Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles

Role: lead

NCT00750451Not ApplicableCompleted

Low Molecular Weight Heparin in Recurrent Implantation Failure

Role: lead

NCT00608010Not ApplicableCompleted

Day 3 Embryo Cryopreservation: Metabolic and Viability Analysis

Role: lead

NCT00521443Completed

Cryosurvival of Embryos From Dysmorphic Oocytes

Role: lead

NCT00516490Not ApplicableCompleted

GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles

Role: lead

All 16 trials loaded